Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02186600Phase 3Completed
A Phase 3 trial of risedronate in osteopenia, sponsored by University of Nebraska. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02186600.